topoisomerase inhibitors (Redx Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nametopoisomerase inhibitors (Redx Pharma)
Drug Alias Nametopoisomerase inhibitors (Redx Pharma/Deinove)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsPseudomonas InfectionsEscherichia coli InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRedx Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRedx Pharma PlcDeinove
Active IndicationsN/A
Inactive IndicationsPseudomonas InfectionsEscherichia coli InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A